We are live on ! Find out more
PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

Back to rankings

3 hedge funds and large institutions have $177K invested in Progenics Pharmaceuticals Inc in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 126 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 129 → 3 (-126)

100% less capital invested

Capital invested by funds: $222M → $177K (-$222M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 126

Holders
3
Holders Change
-126
Holders Change %
-97.67%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
126
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$52.6M
2
FCM
Farallon Capital Management
California
-$31.4M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$21.8M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20.3M
5
State Street
State Street
Massachusetts
-$17.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
101
MetLife Investment Management
New Jersey
– -$47.8K -12,569 Closed
D.E. Shaw & Co
102
D.E. Shaw & Co
New York
– -$46K -12,225 Closed
Rafferty Asset Management
103
Rafferty Asset Management
New York
– -$45K -11,724 Closed
Fifth Third Bancorp
104
Fifth Third Bancorp
Ohio
– -$37K -9,750 Closed
Group One Trading
105
Group One Trading
Illinois
– -$36K -9,478 Closed
AIP
106
Ameritas Investment Partners
Nebraska
– -$29K -7,561 Closed
AIM
107
Aigen Investment Management
New York
– -$26K -6,931 Closed
DSC
108
Duncker Streett & Co
Missouri
– -$25K -6,500 Closed
Zurich Cantonal Bank
109
Zurich Cantonal Bank
Switzerland
– -$18K -4,790 Closed
PNC Financial Services Group
110
PNC Financial Services Group
Pennsylvania
– -$16K -4,277 Closed
MOACM
111
Mutual of America Capital Management
New York
– -$14K -3,772 Closed
Rockefeller Capital Management
112
Rockefeller Capital Management
New York
– -$14K -3,591 Closed
LIA
113
LS Investment Advisors
Michigan
– -$9K -2,272 Closed
Federated Hermes
114
Federated Hermes
Pennsylvania
– -$7K -1,809 Closed
SPIA
115
Steward Partners Investment Advisory
New York
– -$5K -1,500 Closed
VCM
116
Versant Capital Management
Arizona
– -$4K -1,091 Closed
Bank Julius Baer & Co
117
Bank Julius Baer & Co
Switzerland
– -$3K -795 Closed
MAM
118
Meeder Asset Management
Ohio
– -$3K -720 Closed
WT
119
Whittier Trust
California
– -$2K -551 Closed
ASN
120
Advisory Services Network
Georgia
– -$2K -500 Closed
Bank of Montreal
121
Bank of Montreal
Ontario, Canada
– -$1K -419 Closed
SF
122
Synovus Financial
Georgia
– -$1K -333 Closed
CAW
123
Cornerstone Advisors (Washington)
Washington
– -$1K -239 Closed
TFO
124
Tarbox Family Office
California
– -$1K -175 Closed
FWM
125
Filbrandt Wealth Management
Wisconsin
– -$1K -150 Closed
1 2 3 4
5

PGNX Hedge Fund Activity: Q2 2020 in Review

3 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Progenics Pharmaceuticals Inc (PGNX) for Q2 2020, worth a combined $177K — down 100% from $222M a quarter earlier.

Sellers outnumbered buyers: 126 funds closed out of PGNX and 0 opened new positions — a net loss of 126 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $52.6M sold.

  • 3 institutional investors held Progenics Pharmaceuticals Inc (PGNX) as of Q2 2020, down from 129 in Q1 2020.
  • Funds reported $177K of Progenics Pharmaceuticals Inc stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Progenics Pharmaceuticals Inc positions in Q2 2020 and 126 closed out, a net change of -126 holders.
  • The largest Progenics Pharmaceuticals Inc seller in Q2 2020 was BlackRock, an estimated $52.6M sold.

Based on aggregated 13F filings for Q2 2020.